ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2048

Development and Usability Testing of Web-based Standardized Scoring Tool for Magnetic Resonance Images from Children with Chronic Nonbacterial Osteomyelitis (CNO)

Farzana Nuruzzaman1, T. Shawn Sato2, Andrew Carbert3, Joel Paschke3, Lauren Potts4, Meinrad Beer5, Mingqian Huang6, Ramesh Iyer7, Johanna Monsalve8, Anh-Vo Ngo7, Jennifer Stimec9, Mahesh Thapa7, Xiaoyue Zhang10, Walter P. Maksymowych11, Polly Ferguson12 and Yongdong (Dan) Zhao13, 1Stony Brook Children's Hospital, Stony Brook, NY, 2University of Iowa, Iowa City, IA, 3CARE Arthritis, Edmonton, AB, Canada, 4Illustrator/Patient Research Partner, Long Beach, CA, 5University Hospital, Ulm Germany, Ulm, Germany, 6Mount Sinai Hospital, New York, NY, 7University of Washington, Seattle, WA, 8SUNY-Stony Brook Hospital, Stonybrook, NY, 9The Hospital for Sick Children, Toronto, ON, Canada, 10Biostatistical Consulting Core - Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11University of Alberta, Edmonton, AB, Canada, 12University of Iowa Carver College of Medicine, Iowa City, IA, 13University of Washington, Redmond, WA

Meeting: ACR Convergence 2023

Keywords: Autoinflammatory diseases, Imaging, Magnetic resonance imaging (MRI), Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2039–2060) Pediatric Rheumatology – Clinical Poster III: Potpourri

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The ChRonic nonbacterial Osteomyelitis Magnetic Resonance Imaging Scoring (CROMRIS) tool was developed but it was not digitized yet. Our objectives are: 1) to adapt the CROMRIS tool to a web-based platform and 2) assess the usability of this system among radiologists.

Methods: A prototype web-based CROMRIS tool was developed by CARRA’s CNO Workgroup and CARE-Arthritis in 2019. Since then, monthly meetings between software developers, rheumatologists, radiologists and an illustrator led to a beta version that included the whole skeleton. A group of radiologists (n=7) provided feedback on the beta version in a demo session on 4/11/22 via semi-structured surveys (#IRB2021-00033). Usability was assessed by surveys using the System Usability Scale (SUS), a Likert scale in which respondents indicate their level of agreement or disagreement on a scale of 1 to 5 for 10 statements on ease of use, effectiveness, and satisfaction in content of use. Feedback was reported with descriptive content analysis, continuous variables as means and categorical variables as percentages.

Results: A clickable-schematic-based CROMRIS was developed to include all body regions [Figure 1]. Notable features are the ability to immediately highlight a schematic region upon selection to directly input scores. Suggested changes included labeling of individual spine and rib segments, insertion of scoring legend on each tab for reference and creation of a summary page with a composite diagram where one can visualize the location and size of lesions by color as well as a numerical CROMRIS activity index [Figure 2]. The general scoring on the portal is indicated by clicking on a bone unit to indicate the presence of bone marrow hyperintensity consistent with an active CNO lesion, which is qualified by other lesion parameters [Table 1]. A video tutorial and MRI Atlas is on the platform for training (https://www.carearthritis.com/mriportal/crmo/index/).Visual factors and anatomical diagrams were among the features “liked best” by the survey respondents. Mean SUS scores increased from 64.5 (below average) to 75 (above average). All respondents agreed that the final version of the web-based CROMRIS was “easy to learn” and found that the “various functions of the web-based CROMRIS were well integrated, and “would like to use the web-based CROMRIS in future clinical trials.”

Conclusion: The web-based CROMRIS portal shows good usability amongst radiologists. Studies of interrater reliability among experienced pediatric radiologists are underway. Once validated, this tool can be used as a semi-quantitative MRI scoring tool to allow for standardization of reporting output of radiological interpretations of MRI in CNO. The authors wish to acknowledge CARRA and the ongoing Arthritis Foundation financial support of CARRA.

Supporting image 1

Figure 1. Screenshot of Web-based CROMRIS Portal on Tab for Long Bones of Lower Extremity Before and After Feedback Sessions/Usability Testing

Supporting image 2

Figure 2. Screenshot of Summary Page for Final Web-based CROMRIS Portal

Supporting image 3

Table 1. Scoring of Active CNO Lesions in General Bone Units in the Web-Based CROMRIS


Disclosures: F. Nuruzzaman: None; T. Sato: None; A. Carbert: None; J. Paschke: None; L. Potts: None; M. Beer: None; M. Huang: None; R. Iyer: None; J. Monsalve: None; A. Ngo: None; J. Stimec: None; M. Thapa: None; X. Zhang: None; W. Maksymowych: AbbVie, 2, 5, 6, BMS, 2, 6, Boehringer-Ingelheim, 2, CARE Arthritis Ltd, 4, CARE Arthritis Ltd., 4, Celgene, 2, 6, Eli Lilly, 2, 6, Galapagos, 2, 6, Gilead, 2, Janssen, 2, 6, Novartis, 2, 5, 6, Pfizer, 2, 5, 6, UCB, 2, 5, 6; P. Ferguson: None; Y. Zhao: Bristol-Myers Squibb(BMS), 5.

To cite this abstract in AMA style:

Nuruzzaman F, Sato T, Carbert A, Paschke J, Potts L, Beer M, Huang M, Iyer R, Monsalve J, Ngo A, Stimec J, Thapa M, Zhang X, Maksymowych W, Ferguson P, Zhao Y. Development and Usability Testing of Web-based Standardized Scoring Tool for Magnetic Resonance Images from Children with Chronic Nonbacterial Osteomyelitis (CNO) [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/development-and-usability-testing-of-web-based-standardized-scoring-tool-for-magnetic-resonance-images-from-children-with-chronic-nonbacterial-osteomyelitis-cno-2/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-and-usability-testing-of-web-based-standardized-scoring-tool-for-magnetic-resonance-images-from-children-with-chronic-nonbacterial-osteomyelitis-cno-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology